[Federal Register Volume 86, Number 7 (Tuesday, January 12, 2021)]
[Notices]
[Pages 2465-2466]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00331]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2020-0221]


Information Collection: NRC Form 483, ``Registration 
Certificate--In Vitro Testing with Byproduct Material Under General 
License''

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of submission to the Office of Management and Budget; 
request for comment.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) has recently 
submitted a request for renewal of an existing collection of 
information to the Office of Management and Budget (OMB) for review. 
The information collection is entitled, NRC Form 483, ``Registration 
Certificate--In Vitro Testing with Byproduct Material Under General 
License.''

DATES: Submit comments by February 11, 2021. Comments received after 
this date will be considered if it is practical to do so, but the 
Commission is able to ensure consideration only for comments received 
on or before this date.

ADDRESSES: Written comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to https://www.reginfo.gov/public/do/PRAMain. Find this 
particular information collection by selecting ``Currently under 
Review--Open for Public Comments'' or by using the search function.

FOR FURTHER INFORMATION CONTACT: David Cullison, NRC Clearance Officer, 
U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001; 
telephone: 301-415-2084; email: [email protected].

SUPPLEMENTARY INFORMATION:

I. Obtaining Information and Submitting Comments

A. Obtaining Information

    Please refer to Docket ID NRC-2020-0221 when contacting the NRC 
about the availability of information for this action. You may obtain 
publicly available information related to this action by any of the 
following methods:
     Federal Rulemaking Website: Go to https://www.regulations.gov and search

[[Page 2466]]

for Docket ID NRC-2020-0221. A copy of the collection of information 
and related instructions may be obtained without charge by accessing 
Docket ID NRC-2020-0221 on this website.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly available documents online in the 
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``Begin Web-based ADAMS 
Search.'' For problems with ADAMS, please contact the NRC's Public 
Document Room (PDR) reference staff at 1-800-397-4209, 301-415-4737, or 
by email to [email protected]. A copy of the collection of 
information and related instructions may be obtained without charge by 
accessing ADAMS Accession No. ML20205L413. The supporting statement is 
available in ADAMS under Accession No. ML20335A465.
     Attention: The PDR, where you may examine and order copies 
of public documents is currently closed. You may submit your request to 
the PDR via email at [email protected] or call 1-800-397-4209 or 
301-415-4737, between 8:00 a.m. and 4:00 p.m. (EST), Monday through 
Friday, except Federal holidays.
     NRC's Clearance Officer: A copy of the collection of 
information and related instructions may be obtained without charge by 
contacting the NRC's Clearance Officer, David Cullison, Office of the 
Chief Information Officer, U.S. Nuclear Regulatory Commission, 
Washington, DC 20555-0001; telephone: 301-415-2084; email: 
[email protected].

B. Submitting Comments

    The NRC encourages electronic comment submission through the 
Federal Rulemaking website (https://www.regulations.gov). Please 
include Docket ID NRC-2020-0221 in your comment submission.
    The NRC cautions you not to include identifying or contact 
information that you do not want to be publicly disclosed in your 
comment submission. The NRC will post all comment submissions at 
https://www.regulations.gov as well as enter the comment submissions 
into ADAMS. The NRC does not routinely edit comment submissions to 
remove identifying or contact information.
    If you are requesting or aggregating comments from other persons 
for submission to the OMB, then you should inform those persons not to 
include identifying or contact information that they do not want to be 
publicly disclosed in their comment submission. Your request should 
state that comment submissions are not routinely edited to remove such 
information before making the comment submissions available to the 
public or entering the comment into ADAMS.

II. Background

    Under the provisions of the Paperwork Reduction Act of 1995 (44 
U.S.C. Chapter 35), the NRC recently submitted a request for renewal of 
an existing collection of information to OMB for review entitled, NRC 
Form 483, ``Registration Certificate--In Vitro Testing with Byproduct 
Material Under General License.'' The NRC hereby informs potential 
respondents that an agency may not conduct or sponsor, and that a 
person is not required to respond to, a collection of information 
unless it displays a currently valid OMB control number.
    The NRC published a Federal Register notice with a 60-day comment 
period on this information collection on October 8, 2020 (85 FR 63591).
    1. The title of the information collection: NRC Form 483, 
``Registration Certificate--In Vitro Testing with Byproduct Material 
Under General License.''
    2. OMB approval number: 3150-0038.
    3. Type of submission: Extension.
    4. The form number if applicable: NRC Form 483.
    5. How often the collection is required or requested: There is a 
one-time submittal of information to receive a validated copy of the 
NRC Form 483 with an assigned registration number. In addition, any 
changes in the information reported on the NRC Form 483 must be 
reported in writing to the NRC within 30 days after the effective date 
of the change.
    6. Who will be required or asked to respond: Any physician, 
veterinarian in the practice of veterinary medicine, clinical 
laboratory, or hospital which desires a general license to receive, 
acquire, possess, transfer, or use specified units of byproduct 
material in certain in vitro clinical or laboratory tests.
    7. The estimated number of annual responses: 6 responses.
    8. The estimated number of annual respondents: 6 respondents.
    9. An estimate of the total number of hours needed annually to 
comply with the information collection requirement or request: 1.12 
hours.
    10. Abstract: Section 31.11 of title 10 of the Code of Federal 
Regulations (10 CFR), established a general license authorizing any 
physician, clinical laboratory, veterinarian in the practice of 
veterinary medicine, or hospital to possess certain small quantities of 
byproduct material for in vitro clinical or laboratory tests not 
involving the internal or external administration of the byproduct 
material or the radiation therefrom to human beings or animals. 
Possession of byproduct material under 10 CFR 31.11 is not authorized 
until the physician, clinical laboratory, veterinarian in the practice 
of veterinary medicine, or hospital has filed the NRC Form 483 and 
received from the Commission a validated copy of the NRC Form 483 with 
a registration number. The licensee can use the validated copy of the 
NRC Form 483 to obtain byproduct material from a specifically licensed 
supplier. The NRC incorporates this information into a database which 
is used to verify that a general licensee is authorized to receive the 
byproduct material.

    Dated: January 6, 2021.

    For the Nuclear Regulatory Commission.
David C. Cullison,
NRC Clearance Officer, Office of the Chief Information Officer.
[FR Doc. 2021-00331 Filed 1-11-21; 8:45 am]
BILLING CODE 7590-01-P